Microsoft CSO Urges New AI Biosecurity Measures

Microsoft Chief Scientific Officer Eric Horvitz called for better biosecurity to manage AI risks in life sciences ^[1][2]. In a post published June 4, 2026, Horvitz highlighted AI’s dual-use nature as a global challenge ^[1]. While AI tools accelerate drug discovery, they also lower technical barriers to re-engineering pathogens and toxins ^[1].

Horvitz recommended implementing mandatory screening requirements for biological synthesis and research ^[1]. He argued that easier access to biological engineering requires stronger guardrails to prevent intentional misuse ^[1]. These proposals aim to protect scientific progress while ensuring public safety ^[1][2].